BioView blog
Every moment is an opportunity to push your research to its fullest potential. Through our BioView blog, we aspire to keep you informed on research developments, provide insights that support the success of your experiments, and inspire new ideas.
4 factors to consider for immune repertoire profiling
Date: August 8, 2019
Categories: Immune research | Immunotherapy | NGS | Single-cell | Useful resources
Getting ready to sequence T-cell and B-cell receptors? Check out these tips to help you make key decisions before you start.
CAR T-cell therapy: the latest weapon in the fight against cancer
Date: February 14, 2019
Categories: Cancer | Immunotherapy
Learn how CAR T-cell therapies are making cancer treatment targeted, safer, and better.
Maximize viral transduction efficiency in hematopoietic cells, T cells, and other tricky cell types
Date: August 6, 2018
Categories: Immunotherapy | Stem Cells | Viral transduction
Learn how RetroNectin reagent increases transduction efficiency by 50–70% for human CD34+ cells and by 20–30% for mouse bone marrow mononuclear cells.
Efficient nonviral T-cell engineering: CRISPR takes a giant step towards the clinic
Date: July 22, 2018
Categories: CRISPR/Cas9 | Immunotherapy | Research News
Learn about the development of a powerful new method for reprogramming T cells.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
